-->

Trump’s Policies Are Shifting the Market—Here’s How to Play It

Post a Comment

Hi Traders and Investors,

It’s been six months since Trump returned to the White House—and the impact on markets is already taking shape.

From new policy rollouts to shifting economic priorities, we’re entering a new phase of opportunity for investors who know where to look.

That’s why we’ve just released a brand-new report:
"5 Best Stocks to Buy Under Trump’s Presidency"
[Download Your Free Report Here]

Inside, you’ll discover:

  • Which sectors are showing early momentum under the new administration

  • 5 stocks uniquely positioned for potential long-term gains

  • Strategic insights to help align your portfolio with today’s evolving landscape

The market doesn’t wait—and neither should you.
Now’s the time to get positioned while many investors are still adjusting.

[Access the Report: 5 Stocks for Trump’s America]

Best regards,
The Investment News Daily Team

(By following any of the links above, you're choosing to opt in to receive insightful updates from The Investment News Daily + 2 free bonus subscriptions! Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details.)


 
 
 
 
 
 

Tuesday's Bonus Content

Is Tilray's Stock Price Surge a Pipe Dream of Political Hype?

Written by Jeffrey Neal Johnson. Published 10/1/2025.

CBD oil cannabis extract, Hemp oil bottles and hemp flowers on a wooden table, Medical cannabis concept — Photo

Key Points

  • A major political endorsement for CBD sparked a powerful, sector-wide rally, positioning Tilray at the forefront of a significant shift in market sentiment.
  • A classic short squeeze dynamic amplified the company's rally, as a large number of bearish bets were forced to unwind in a single session.
  • Recent insider buying from top executives signals strong internal confidence in the company's long-term strategy and fundamental valuation.

On Sept. 29, shares of Tilray Brands (NASDAQ: TLRY) surged over 60%, closing at $1.85 per share. Trading volume exploded to more than 371 million shares—over eight times its daily average of 44.65 million—driving the session's dramatic move.

Such a spike, fueled by external political news, poses an immediate question for investors: was this merely a fleeting, sentiment-driven bump, or does it mark the market's recognition of a deeper value proposition within Tilray?

Nvidia Gained 156,000%… (Ad)

A Millionaire With SEVEN Clicks?

$1,000 in just seven stocks in 2004 could have turned into a million-dollar portfolio today…

Back then… one financial expert begged people to look at Nvidia -- when it was trading at just $1.10!

Now… he's urging you to look at a new group of seven stocks…

Check this Out (The NEXT Magnificent Seven)tc pixel

While the administrative catalyst was speculative, it cast a much-needed spotlight on a company with strong fundamentals, ample cash reserves and a technical setup primed for further upside. That combination could spur a long-term re-rating of Tilray's stock and even the broader marijuana sector.

A Perfect Storm of News and Technicals

The spark that ignited the rally was a video released by the current administration highlighting the medical potential of CBD for seniors. Markets interpreted this as a de-risking signal for U.S. cannabis regulation, sending shockwaves through the sector and lifting Tilray as one of the biggest beneficiaries.

Yet the political shift was only the spark. The fuel came from Tilray's technical setup: the stock carried a short interest of 14.8% of its float—over 161 million shares bet against by short sellers. When the positive news hit, those shorts were forced to cover, triggering a classic short squeeze.

As short sellers bought shares to close positions and limit losses, their forced demand added to organic buying, creating a feedback loop that drove Tilray's share price into an explosive vertical rally.

Tilray's Fundamental Strength

Beyond the one-day fireworks, Tilray has quietly been building a solid foundation. Recent developments highlight that the company is more than just a speculative cannabis play—it's showing real operational and financial progress.

  • Fortified Balance Sheet: Tilray holds $256 million in cash and marketable securities and has reduced total debt by nearly $100 million over the past year. This has resulted in a conservative debt-to-equity ratio of 0.20, providing a cushion against volatility and the flexibility to invest in growth. [Financials]
  • Profitable Growth Engines: In fiscal 2025, Tilray's high-margin international cannabis business saw revenue climb 19%, and global cannabis gross margins expanded by 700 basis points. Its U.S. beverage alcohol segment also grew revenue by 19%, and Project 420—a profitability-focused restructuring plan—has already delivered $24 million in annualized savings toward its $33 million goal.
  • Insider Confidence: Management has put its money where its mouth is. SEC filings from July 2025 show open-market purchases by CEO Irwin Simon and CFO Carl Merton, a powerful signal that insiders believe the stock is undervalued and are confident in Tilray's long-term strategy.

The Next Checkpoint: All Eyes on October 9

The recent rally faces its first real test when Tilray reports first-quarter fiscal 2026 results before the market opens on Oct. 9, 2025. This release will be the first hard data point since year-end and will determine whether the momentum can be sustained.

Investors should watch for top-line growth in the international cannabis division, tangible progress from Project 420 cost savings in the beverage segment, and confirmation of full-year adjusted EBITDA guidance of $62 million to $72 million. In the previous quarter, Tilray beat EPS estimates but missed revenue targets, making these metrics critical.

Tilray now trades near the consensus analyst price target of $1.94. A strong report that meets or exceeds expectations could prompt a fresh Wall Street re-evaluation and validate a higher share price. The administration's comments may have opened the door, but operational execution will decide if the rally can continue.


 
Thank you for subscribing to TickerReport, where we work around-the-clock
to bring you the latest market-moving news.
 
This email content is a sponsored message provided by Darwin, a third-party advertiser of TickerReport and MarketBeat.
 
Contact Us  |  Unsubscribe
 
© 2006-2025 MarketBeat Media, LLC dba TickerReport. All rights protected.
345 N Reid Place, Sixth Floor, Sioux Falls, SD 57103-7078. United States..

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter